Rilonacept
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 283 publications
Targeting IL-1 in SLE-Associated Recurrent Pericarditis: A Case Series and Review of Mechanistic Rationale.
Journal: Journal of cardiovascular pharmacology
Published: August 19, 2026
Multiyear Recurrent Pericarditis Disease Duration: Clinical Outcomes After Cessation of Long-Term Interleukin-1 Pathway Inhibition Provide Insights for Chronic Management.
Journal: Journal of the American Heart Association
Published: July 28, 2026
Management of pericarditis: recent advances.
Journal: Polish archives of internal medicine
Published: June 30, 2026
Pathway for the Diagnosis and Management of Pericardial Disease: Contemporary Perspective.
Journal: Critical pathways in cardiology
Published: June 22, 2026
Cardioimmunology of Myocarditis: Targeting the IL-1 Pathway.
Journal: Current cardiology reports
Published: May 17, 2026
Retraction Note: Real-world data and Mendelian randomization analysis in assessing adverse reactions of rilonacept.
Journal: International journal of clinical pharmacy
Published: May 13, 2026
Recurrent Pericarditis in a Rugby Player: Imaging-Guided Therapy.
Journal: JACC. Case reports
Published: April 15, 2026
Interleukin-1: from discovery to therapeutic targeting of the first cytokine.
Journal: Allergology international : official journal of the Japanese Society of Allergology
Published: March 02, 2026
Updates on Pathophysiology of Pericarditis to Guide Development of Therapeutics.
Journal: Current cardiology reports
Published: February 10, 2026
Recurrent Sterile Pleuropericarditis After Withdrawal of Renal Transplant Immunosuppression in Anuric ESRD: A Case of Suspected IL-1-Mediated Autoinflammation.
Journal: Case reports in rheumatology
Published: February 07, 2026
Targeting cytokine pathways: the role of biologics in autoinflammatory disorders.
Journal: Expert review of clinical immunology
Published: February 01, 2026
Comment on "Risk of Pericarditis Recurrence Associated With Rilonacept and NSAID/Colchicine Therapy After Initial Pericarditis Presentation: A Retrospective Real-World Comparative Risk Analysis With TriNetX".
Journal: American journal of therapeutics
Published: January 29, 2026
Last Updated: 09/26/2026